AngioDynamics, Inc. (ANGO)

AngioDynamics Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019
Net Income	-52.44	-26.55	-31.55	-166.79	61.34
Depreciation & Amortization	33.36	31.79	28.37	25.88	25.88
Share-Based Compensation	11.16	10.69	8.63	7.59	9.25
Other Operating Activities	8.01	-23.13	18.64	118.77	-59.03
Operating Cash Flow	0.08	-7.19	24.09	-14.55	37.44
Operating Cash Flow Growth	-	-	-	-	-9.32%
Capital Expenditures	-9.21	-15.71	-13.71	-7.24	-3.12
Acquisitions	0	-3.6	0	-55.76	84.32
Change in Investments	0	0	0	0	1.35
Other Investing Activities	-0.54	-	-	-0.35	-
Investing Cash Flow	-9.75	-19.31	-13.71	-63.35	82.55
Share Issuance / Repurchase	1.17	2.68	3.01	-0.76	2.03
Debt Issued / Paid	25	5	-20	-92.5	40
Other Financing Activities	-0.75	-	-	-1.98	-8.1
Financing Cash Flow	25.42	7.68	-16.99	-95.24	33.93
Exchange Rate Effect	0.04	-0.52	0.33	-0.07	-0.38
Net Cash Flow	15.8	-19.34	-6.27	-173.21	153.55
Free Cash Flow	-9.13	-22.9	10.38	-21.79	34.32
Free Cash Flow Growth	-	-	-	-	-11.76%
Free Cash Flow Margin	-2.69%	-7.24%	3.57%	-8.25%	12.68%
Free Cash Flow Per Share	-0.23	-0.59	0.27	-0.57	0.92

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).